Skip to content
Open access

Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis Patients With Severe Lung Disease Carrying Previously Ineligible CFTR Mutations

Sep 2026 · Open Respiratory Archives · Vol 8 · 0 citations
Medicine

Abstract

Graphical abstract

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.